ReviewImmunology and allergy clinics of North America2026
Anaphylaxis: Clinical Criteria, Severity, and Clinical Courses.
Review in Immunology and allergy clinics of North America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Anaphylaxis is a potentially life-threatening allergic reaction that is increasing worldwide. While it is often straightforward to diagnose, at times the diagnosis remains uncertain, especially if there is no clear trigger, symptoms overlap with other conditions, or patients mainly report subjective symptoms without confirmatory physical findings. Unfortunately, there is no gold-standard test for diagnosing anaphylaxis, so clinicians must rely on clinical criteria to assess its likelihood. The first widely accepted clinical criteria were published in 2006 by the National Institute of Allergy and Infectious Diseases and the Food Allergy and Anaphylaxis Network, and in 2020, the World Allergy Organization proposed updates to these criteria. The new 2024 Anaphylaxis Clinical Support Tool addresses discrepanices between previous criteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.